TrialNature communications2025

Poziotinib for EGFR exon 20-insertion NSCLC: Clinical efficacy of the phase 2 ZENITH trial and differential impact of EGFR exon 20 insertion location on sensitivity.

Xiuning Le et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.